🔴 Moleculin Biotech is trading 6.3% down today as Nasdaq and S&P 500 fall

Moleculin Biotech is trading 6.3% lower at $5.91 on October 22, 2026, amid broad U.S. market weakness; risk-off sentiment is the most plausible available explanation.

• The Nasdaq Composite is down 1.57%, and the S&P 500 is down 0.98%.
• No clear company-specific announcement dated October 22 was found. The MIRACLE trial update and reverse-split news date to October 20; the update anticipated a Q1 2027 data readout.